Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, giving promising improvements across many healthcare and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, extra reputable option for therapeutic use, especially